Health Canada provided preliminary data regarding cannabis demand and supply for the month of December:
The data is broken down by medical and non-medical, both of which saw dried flower sales increase, with medical cannabis flower sales rising 1% from revised November levels while adult-use flower sales grew 5.3% in terms of kilograms. Oils for medical patients fell 2.9% but grew 14% for adult-use. In total, flower grew 4.2%, while oil grew 1.6%.
Finished inventory fell 4.3% for dried flower and grew 14.4% for oils. Unfinished inventory saw large increases for both dried flower and oils, with flower increasing 11.8% and oils growing 12.8% from November levels.
Published by Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email